Similarly, CEA reduction after 1 month of EGFR-TKI therapy was significantly correlated with DCR and PFS in EGFR wild-type/unknown but not in mutated NSCLC cases [21]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.